Bora Pharmaceuticals Co., Ltd. engages in the manufacturing and sales of generic, brand, and over-the-counter drugs. Its products include central nervous system medication, cardiovascular medicine, antibiotics, antivirals, ophthalmic, antipsychotics, dementia drugs, sleeping agents, lowering blood pressure drugs, and health food. The firm operates through the following segments: Sales, Manufacturing, and Other Segment. The Sales segment comprises of the pharmaceuticals and healthcare products. The Manufacturing segment consists of Contract development & manufacturing organization of pharmaceuticals. The Other Segment refers to the distributing and developing pharmaceuticals. Bora Pharmaceuticals was founded on June 12, 2007 and is headquartered in Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company